Cite
HARVARD Citation
Lobo, R. et al. (2019). Estradiol and progesterone bioavailability for moderate to severe vasomotor symptom treatment and endometrial protection with the continuous-combined regimen of TX-001HR (oral estradiol and progesterone capsules). Menopause. 26 (7), p. . [Online].